Beneficial effects of teucrium polium and metformin on diabetes-induced memory impairments and brain tissue oxidative damage in rats

International Journal of Alzheimer's Disease

Volumn 2015, Issue , 2015, Pages

  Mousavi, S Mojtaba ^a   Niazmand, Saeed ^a   Hosseini, Mahmoud ^b   Hassanzadeh, Zarha ^b   Sadeghnia, Hamid Reza ^c   Vafaee, Farzaneh ^a   Keshavarzi, Zakieh ^d  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d NORTH KHORASAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LIPID PEROXIDE; MALONALDEHYDE; METFORMIN; TEUCRIUM POLIUM EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN TISSUE; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTRIC SHOCK; GERMANDER; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; LATENT PERIOD; LIPID BLOOD LEVEL; LONG TERM CARE; MALE; MEMORY DISORDER; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE TEST; PRIORITY JOURNAL; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS;

EID: 84924560239     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.1155/2015/493729     Document Type: Article

References (132)

1. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, "Global prevalence of diabetes: estimates for the year 2000 and projections for 2030," Diabetes Care, Vol. 27, no. 5, pp. 1047-1053, 2004.
2. A. L. McCall, "The impact of diabetes on the CNS," Diabetes, Vol. 41, no. 5, pp. 557-570, 1992.
3. W. H. Gispen and G.-J. Biessels, "Cognition and synaptic plasticity in diabetes mellitus," Trends in Neurosciences, Vol. 23, no. 11, pp. 542-549, 2000.
4. C. M. Ryan, "Neurobehavioral complications of type I diabetes. Examination of possible risk factors," Diabetes Care, Vol. 11, no. 1, pp. 86-93, 1988.
5. G. M. Reaven, L. W. Thompson, D. Nahum, and E. Haskins, "Relationship between hyperglycemia and cognitive function in older NIDDM patients," Diabetes Care, Vol. 13, no. 1, pp. 16-21, 1990.
6. P. A. Tun, D. M. Nathan, and L. C. Perlmuter, "Cognitive and affective disorders in elderly diabetics," Clinics in Geriatric Medicine, Vol. 6, no. 4, pp. 731-746, 1990.
7. R. Stewart and D. Liolitsa, "Type 2 diabetes mellitus, cognitive impairment and dementia," Diabetic Medicine, Vol. 16, no. 2, pp. 93-112, 1999.
8. K. Fukui, K. Onodera, T. Shinkai, S. Suzuki, and S. Urano, "Impairment of learning and memory in rats caused by oxidative stress and aging, and changes in antioxidative defense systems," Annals of the New York Academy of Sciences, Vol. 928, pp. 168-175, 2001.
9. G. Baydas, V. S. Nedzvetskii, P. A. Nerush, S. V. Kirichenko, and T. Yoldas, "Altered expression of NCAM in hippocampus and cortex may underlie memory and learning deficits in rats with streptozotocin-induced diabetes mellitus," Life Sciences, Vol. 73, no. 15, pp. 1907-1916, 2003.
10. C. L. Hawkins and M. J. Davies, "Generation and propagation of radical reactions on proteins," Biochimica et Biophysica Acta - Bioenergetics, Vol. 1504, no. 2-3, pp. 196-219, 2001.
11. E. M. Galati, M. R. Mondello, A. D'Aquino et al., "Effects of Teucrium divaricatum Heldr. ssp. divaricatum decoction on experimental ulcer in rats," Journal of Ethnopharmacology, Vol. 72, no. 1-2, pp. 337-342, 2000.
12. M. N. Gharaibeh, H. E. Elayan, and A. S. Salhab, "Hypoglycemic effects of teucrium polium," Journal of Ethnopharmacology, Vol. 24, no. 1, pp. 93-99, 1988.
13. M. Tariq, A. M. Ageel, M. A. Al-Yahya, J. S. Mossa, and M. S. Al-Said, "Anti-inflammatory activity of Teucrium polium," International Journal of Tissue Reactions, Vol. 11, no. 4, pp. 185-188, 1989.
14. M. A. Esmaeili and R. Yazdanparast, "Hypoglycaemic effect of Teucrium polium: studies with rat pancreatic islets," Journal of Ethnopharmacology, Vol. 95, no. 1, pp. 27-30, 2004.
15. S. E. Mousavi, A. Shahriari, A. Ahangarpour, H. Vatanpour, and A. Jolodar, "Effects of Teucrium polium ethyl acetate extract on serum, liver and muscle triglyceride content of sucrose-induced insulin resistance in rat," Iranian Journal of Pharmaceutical Research, Vol. 11, no. 1, pp. 347-355, 2012.
16. S. Niazmand, M. Esparham, T. Hassannia, and M. Derakhshan, "Cardiovascular effects of Teucrium polium L. extract in rabbit," Pharmacognosy Magazine, Vol. 7, no. 27, pp. 260-264, 2011.
17. M.-S. Suleiman, A.-S. Abdul-Ghani, S. Al-Khalil, and R. Amin, "Effect of Teucrium polium boiled leaf extract on intestinal motility and blood pressure," Journal of Ethnopharmacology, Vol. 22, no. 1, pp. 111-116, 1988.
18. H. R. Rasekh, M. J. Khoshnood-Mansourkhani, and M. Kamalinejad, "Hypolipidemic effects of Teucrium polium in rats," Fitoterapia, Vol. 72, no. 8, pp. 937-939, 2001.
19. M. Abdollahi, H. Karimpour, and H. R. Monsef-Esfehani, "Antinociceptive effects of Teucrium polium L. total extract and essential oil in mouse writhing test," Pharmacological Research, Vol. 48, no. 1, pp. 31-35, 2003.
20. M. Couladis, O. Tzakou, E. Verykokidou, and C. Harvala, "Screening of some Greek aromatic plants for antioxidant activity," Phytotherapy Research, Vol. 17, no. 2, pp. 194-195, 2003.
21. H. Kalantari, H. Forouzandeh, M. E. Azemi, I. Rashidi, and M. Goudarzi, "Study of the protective effect of Teucrium polium L. extract on acetaminophen-induced hepatotoxicity in mice," Iranian Journal of Pharmaceutical Research, Vol. 12, no. 1, pp. 123-129, 2013.
22. P. Hasanein and S. Shahidi, "Preventive effect of Teucrium polium on learning and memory deficits in diabetic rats," Medical Science Monitor, Vol. 18, no. 1, pp. BR41-BR46, 2012.
23. Z. Rajaei, M.-A. Hadjzadeh, H. Nemati, M. Hosseini, M. Ahmadi, and S. Shafiee, "Antihyperglycemic and antioxidant activity of crocin in streptozotocin-induced diabetic rats," Journal of Medicinal Food, Vol. 16, no. 3, pp. 206-210, 2013.
24. S. Taleb, P. Moghaddas, M. Rahimi Balaei et al., "Metformin improves skin flap survival through nitric oxide system," Journal of Surgical Research, Vol. 192, no. 2, pp. 686-691, 2014.
25. S. M. Naghibi, M. Hosseini, F. Khani et al., "Effect of aqueous extract of Crocus sativus L. on morphine-induced memory impairment," Advances in Pharmacological Sciences, Vol. 2012, Article ID 494367, 7 pages, 2012.
26. G. L. Ellman, "Tissue sulfhydryl groups," Archives of Biochemistry and Biophysics, Vol. 82, no. 1, pp. 70-77, 1959.
27. M. Hosseini, M. Pourganji, F. Khodabandehloo, M. Soukhtanloo, and H. Zabihi, "Protective effect of L-Arginine against oxidative damage as a possible mechanism of its beneficial properties on spatial learning in ovariectomized rats," Basic and Clinical Neuroscience, Vol. 3, no. 5, pp. 36-44, 2012.
28. F. Khodabandehloo, M. Hosseini, Z. Rajaei, M. Soukhtanloo, E. Farrokhi, and M. Rezaeipour, "Brain tissue oxidative damage as a possible mechanism for the deleterious effect of a chronic high dose of estradiol on learning and memory in ovariectomized rats," Arquivos de Neuro-Psiquiatria, Vol. 71, no. 5, pp. 313-339, 2013.
29. G.-J. Biessels, A. Kamal, G. M. Ramakers et al., "Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats," Diabetes, Vol. 45, no. 9, pp. 1259-1266, 1996.
30. M. W. J. Strachan, B. M. Frier, and I. J. Deary, "Type 2 diabetes and cognitive impairment," Diabetic Medicine, Vol. 20, no. 1, pp. 1-2, 2003.
31. A. J. Sommerfield, I. J. Deary, and B. M. Frier, "Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes," Diabetes Care, Vol. 27, no. 10, pp. 2335-2340, 2004.
32. G.-J. Biessels, A. Kamal, I. J. A. Urban, B. M. Spruijt, D. W. Erkelens, and W. H. Gispen, "Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment," Brain Research, Vol. 800, no. 1, pp. 125-135, 1998.
33. E. Tamaddonfard, A. A. Farshid, S. Asri-Rezaee et al., "Crocin improved learning and memory impairments in streptozotocin-induced diabetic rats," Iranian Journal of Basic Medical Sciences, Vol. 16, no. 1, pp. 91-100, 2013.
34. G. Baydas, H. Canatan, and A. Turkoglu, "Comparative analysis of the protective effects of melatonin and vitamin E on streptozocin-induced diabetes mellitus," Journal of Pineal Research, Vol. 32, no. 4, pp. 225-230, 2002.
35. S. Celik, G. Bayda, and O. Ylmaz, "Influence of vitamin E on the levels of fatty acids and MDA in some tissues of diabetic rats," Cell Biochemistry & Function, Vol. 20, no. 1, pp. 67-71, 2002.
36. G. Baydas, E. Sonkaya, M. Tuzcu, A. Yasar, and E. Donder, "Novel role for gabapentin in neuroprotection of central nervous system in streptozotocine-induced diabetic rats," Acta Pharmacologica Sinica, Vol. 26, no. 4, pp. 417-422, 2005.
37. J. B. Majithiya and R. Balaraman, "Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats," Life Sciences, Vol. 78, no. 22, pp. 2615-2624, 2006.
38. C. M. Sena, P. Matafome, T. Louro, E. Nunes, R. Fernandes, and R. M. Seiça, "Metformin restores endothelial function in aorta of diabetic rats," British Journal of Pharmacology, Vol. 163, no. 2, pp. 424-437, 2011.
39. P. Faure, E. Rossini, N. Wiernsperger, M. J. Richard, A. Favier, and S. Halimi, "An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats," Diabetes, Vol. 48, no. 2, pp. 353-357, 1999.
40. D. Bonnefont-Rousselot, B. Raji, S. Walrand et al., "An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress," Metabolism, Vol. 52, no. 5, pp. 586-589, 2003.
41. D. Stepensky, M. Friedman, I. Raz, and A. Hoffman, "Pharmacokinetic-pharmacodynamic analysis of the glucose-lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect," Drug Metabolism and Disposition, Vol. 30, no. 8, pp. 861-868, 2002.
42. C. J. Bailey and R. C. Turner, "Metformin," The New England Journal of Medicine, Vol. 334, no. 9, pp. 574-579, 1996.
43. J. L. Sartoretto, G. A. N. Melo, M. H. C. Carvalho et al., "Metformin treatment restores the altered microvascular reactivity in neonatal streptozotocin-induced diabetic rats increasing NOS activity, but not NOS expression," Life Sciences, Vol. 77, no. 21, pp. 2676-2689, 2005.
44. G. M. Rubanyi, J. C. Romero, and P. M. Vanhoutte, "Flow-induced release of endothelium-derived relaxing factor," The American Journal of Physiology - Heart and Circulatory Physiology, Vol. 250, no. 6, pp. H822-H827, 1986.
45. K. Kamata and T. Kobayashi, "Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes," British Journal of Pharmacology, Vol. 119, no. 3, pp. 583-589, 1996.
46. R. Sadeghian, M. Fereidoni, M. Soukhtanloo, H. Azizi-Malekabadi, and M. Hosseini, "Decreased nitric oxide levels in the hippocampus may play a role in learning and memory deficits in ovariectomized rats treated by a high dose of estradiol," Arquivos de Neuro-Psiquiatria, Vol. 70, no. 11, pp. 874-879, 2012.
47. P. Gargiulo, D. Caccese, P. Pignatelli et al., "Metformin decreases platelet superoxide anion production in diabetic patients," Diabetes/Metabolism Research and Reviews, Vol. 18, no. 2, pp. 156-159, 2002.
48. C. Bellin, D. H. De Wiza, N. F. Wiernsperger, and P. Rösen, "Generation of reactive oxygen species by endothelial and smooth muscle cells: influence of hyperglycemia and metformin," Hormone and Metabolic Research, Vol. 38, no. 11, pp. 732-739, 2006.
49. C. J. Bailey, C. Wilcock, and J. H. B. Scarpello, "Metformin and the intestine," Diabetologia, Vol. 51, no. 8, pp. 1552-1553, 2008.
50. G. Kanigür-Sultuybek, Ş. B. Ozdas, A. Curgunlu, V. Tezcan, and I. Onaran, "Does metformin prevent short-term oxidant-induced DNA damage? In vitro study on lymphocytes from aged subjects," Journal of Basic and Clinical Physiology and Pharmacology, Vol. 18, no. 2, pp. 129-140, 2007.
51. P. Rösen and N. F. Wiernsperger, "Metformin delays the manifestation of diabetes and vascular dysfunction in Goto-Kakizaki rats by reduction of mitochondrial oxidative stress," Diabetes/Metabolism Research and Reviews, Vol. 22, no. 4, pp. 323-330, 2006.
52. N. Ouslimani, M. Mahrouf, J. Peynet et al., "Metformin reduces endothelial cell expression of both the receptor for advanced glycation end products and lectin-like oxidized receptor 1," Metabolism: Clinical and Experimental, Vol. 56, no. 3, pp. 308-313, 2007.
53. I. Orhan and M. Aslan, "Appraisal of scopolamine-induced antiamnesic effect in mice and in vitro antiacetylcholinesterase and antioxidant activities of some traditionally used Lamiaceae plants," Journal of Ethnopharmacology, Vol. 122, no. 2, pp. 327-332, 2009.
54. R. Alcázar, M. C. De la Torre, B. Rodríguez et al., "Neoclerodane diterpenoids from three species of Teucrium," Phytochemistry, Vol. 31, no. 11, pp. 3957-3960, 1992.
55. S. Bahramikia and R. Yazdanparast, "Phytochemistry and medicinal properties of Teucrium polium L. (Lamiaceae)," Phytotherapy Research, Vol. 26, no. 11, pp. 1581-1593, 2012.
56. A. Ansari Asl, M. Soveid, M. Azadbakht, G. R. Omrani, S. M. Solimani, and M. Samani, "The effect of extract of Teucrium polium on blood sugar and insulin levels of type 2 diabetic patients," Shiraz Medical Journal, Vol. 1, no. 1, pp. 1-5, 2000.
57. P. Ljubuncic, S. Dakwar, I. Portnaya, U. Cogan, H. Azaizeh, and A. Bomzon, "Aqueous extracts of Teucrium polium possess remarkable antioxidant activity in vitro," Evidence-Based Complementary and Alternative Medicine, Vol. 3, no. 3, pp. 329-338, 2006.
58. S. M. Suboh, Y. Y. Bilto, and T. A. Aburjai, "Protective effects of selected medicinal plants against protein degradation, lipid peroxidation and deformability loss of oxidatively stressed human erythrocytes," Phytotherapy Research, Vol. 18, no. 4, pp. 280-284, 2004.
59. T. K. Panovska, S. Kulevanova, and M. Stefova, "In vitro antioxidant activity of some Teucrium species (Lamiaceae)," Acta Pharmaceutica, Vol. 55, no. 2, pp. 207-214, 2005.
60. K. I. Qabaha, "Antimicrobial and free radical scavenging activities of five Palestinian medicinal plants," African Journal of Traditional, Complementary and Alternative Medicines, Vol. 10, no. 4, pp. 101-108, 2013.
61. C. Proestos, D. Sereli, and M. Komaitis, "Determination of phenolic compounds in aromatic plants by RP-HPLC and GCMS," Food Chemistry, Vol. 95, no. 1, pp. 44-52, 2006.
62. M. Rafieian-Kopaei and H. Nasri, "Comment on: preventive effect of Teucrium polium on learning and memory deficits in diabetic rats," Medical Science Monitor Basic Research, Vol. 19, pp. 208-209, 2013.
63. J. W. Baynes, "Role of oxidative stress in development of complications in diabetes," Diabetes, Vol. 40, no. 4, pp. 405-412, 1991.
64. A. Lapolla and D. Fedele, "Oxidative stress and diabetes: role in the development of chronic complications," Minerva Endocrinologica, Vol. 18, no. 3, pp. 99-108, 1993.
65. C. Luxford, R. T. Dean, and M. J. Davies, "Radicals derived from histone hydroperoxides damage nucleobases in RNA and DNA," Chemical Research in Toxicology, Vol. 13, no. 7, pp. 665-672, 2000.
66. K. Fukui, N.-O. Omoi, T. Hayasaka et al., "Cognitive impairment of rats caused by oxidative stress and aging, and its prevention by vitamin E," Annals of the New York Academy of Sciences, Vol. 959, pp. 275-284, 2002.
67. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, "Global prevalence of diabetes: estimates for the year 2000 and projections for 2030," Diabetes Care, Vol. 27, no. 5, pp. 1047-1053, 2004.
68. A. L. McCall, "The impact of diabetes on the CNS," Diabetes, Vol. 41, no. 5, pp. 557-570, 1992.
69. W. H. Gispen and G.-J. Biessels, "Cognition and synaptic plasticity in diabetes mellitus," Trends in Neurosciences, Vol. 23, no. 11, pp. 542-549, 2000.
70. C. M. Ryan, "Neurobehavioral complications of type I diabetes. Examination of possible risk factors," Diabetes Care, Vol. 11, no. 1, pp. 86-93, 1988.
71. G. M. Reaven, L. W. Thompson, D. Nahum, and E. Haskins, "Relationship between hyperglycemia and cognitive function in older NIDDM patients," Diabetes Care, Vol. 13, no. 1, pp. 16-21, 1990.
72. P. A. Tun, D. M. Nathan, and L. C. Perlmuter, "Cognitive and affective disorders in elderly diabetics," Clinics in Geriatric Medicine, Vol. 6, no. 4, pp. 731-746, 1990.
73. R. Stewart and D. Liolitsa, "Type 2 diabetes mellitus, cognitive impairment and dementia," Diabetic Medicine, Vol. 16, no. 2, pp. 93-112, 1999.
74. K. Fukui, K. Onodera, T. Shinkai, S. Suzuki, and S. Urano, "Impairment of learning and memory in rats caused by oxidative stress and aging, and changes in antioxidative defense systems," Annals of the New York Academy of Sciences, Vol. 928, pp. 168-175, 2001.
75. G. Baydas, V. S. Nedzvetskii, P. A. Nerush, S. V. Kirichenko, and T. Yoldas, "Altered expression of NCAM in hippocampus and cortex may underlie memory and learning deficits in rats with streptozotocin-induced diabetes mellitus," Life Sciences, Vol. 73, no. 15, pp. 1907-1916, 2003.
76. C. L. Hawkins and M. J. Davies, "Generation and propagation of radical reactions on proteins," Biochimica et Biophysica Acta - Bioenergetics, Vol. 1504, no. 2-3, pp. 196-219, 2001.
77. E. M. Galati, M. R. Mondello, A. D'Aquino et al., "Effects of Teucrium divaricatum Heldr. ssp. divaricatum decoction on experimental ulcer in rats," Journal of Ethnopharmacology, Vol. 72, no. 1-2, pp. 337-342, 2000.
78. M. N. Gharaibeh, H. E. Elayan, and A. S. Salhab, "Hypoglycemic effects of teucrium polium," Journal of Ethnopharmacology, Vol. 24, no. 1, pp. 93-99, 1988.
79. M. Tariq, A. M. Ageel, M. A. Al-Yahya, J. S. Mossa, and M. S. Al-Said, "Anti-inflammatory activity of Teucrium polium," International Journal of Tissue Reactions, Vol. 11, no. 4, pp. 185-188, 1989.
80. M. A. Esmaeili and R. Yazdanparast, "Hypoglycaemic effect of Teucrium polium: studies with rat pancreatic islets," Journal of Ethnopharmacology, Vol. 95, no. 1, pp. 27-30, 2004.
81. S. E. Mousavi, A. Shahriari, A. Ahangarpour, H. Vatanpour, and A. Jolodar, "Effects of Teucrium polium ethyl acetate extract on serum, liver and muscle triglyceride content of sucrose-induced insulin resistance in rat," Iranian Journal of Pharmaceutical Research, Vol. 11, no. 1, pp. 347-355, 2012.
82. S. Niazmand, M. Esparham, T. Hassannia, and M. Derakhshan, "Cardiovascular effects of Teucrium polium L. extract in rabbit," Pharmacognosy Magazine, Vol. 7, no. 27, pp. 260-264, 2011.
83. M.-S. Suleiman, A.-S. Abdul-Ghani, S. Al-Khalil, and R. Amin, "Effect of Teucrium polium boiled leaf extract on intestinal motility and blood pressure," Journal of Ethnopharmacology, Vol. 22, no. 1, pp. 111-116, 1988.
84. H. R. Rasekh, M. J. Khoshnood-Mansourkhani, and M. Kamalinejad, "Hypolipidemic effects of Teucrium polium in rats," Fitoterapia, Vol. 72, no. 8, pp. 937-939, 2001.
85. M. Abdollahi, H. Karimpour, and H. R. Monsef-Esfehani, "Antinociceptive effects of Teucrium polium L. total extract and essential oil in mouse writhing test," Pharmacological Research, Vol. 48, no. 1, pp. 31-35, 2003.
86. M. Couladis, O. Tzakou, E. Verykokidou, and C. Harvala, "Screening of some Greek aromatic plants for antioxidant activity," Phytotherapy Research, Vol. 17, no. 2, pp. 194-195, 2003.
87. H. Kalantari, H. Forouzandeh, M. E. Azemi, I. Rashidi, and M. Goudarzi, "Study of the protective effect of Teucrium polium L. extract on acetaminophen-induced hepatotoxicity in mice," Iranian Journal of Pharmaceutical Research, Vol. 12, no. 1, pp. 123-129, 2013.
88. P. Hasanein and S. Shahidi, "Preventive effect of Teucrium polium on learning and memory deficits in diabetic rats," Medical Science Monitor, Vol. 18, no. 1, pp. BR41-BR46, 2012.
89. Z. Rajaei, M.-A. Hadjzadeh, H. Nemati, M. Hosseini, M. Ahmadi, and S. Shafiee, "Antihyperglycemic and antioxidant activity of crocin in streptozotocin-induced diabetic rats," Journal of Medicinal Food, Vol. 16, no. 3, pp. 206-210, 2013.
90. S. Taleb, P. Moghaddas, M. Rahimi Balaei et al., "Metformin improves skin flap survival through nitric oxide system," Journal of Surgical Research, Vol. 192, no. 2, pp. 686-691, 2014.
91. S. M. Naghibi, M. Hosseini, F. Khani et al., "Effect of aqueous extract of Crocus sativus L. on morphine-induced memory impairment," Advances in Pharmacological Sciences, Vol. 2012, Article ID 494367, 7 pages, 2012.
92. G. L. Ellman, "Tissue sulfhydryl groups," Archives of Biochemistry and Biophysics, Vol. 82, no. 1, pp. 70-77, 1959.
93. M. Hosseini, M. Pourganji, F. Khodabandehloo, M. Soukhtanloo, and H. Zabihi, "Protective effect of L-Arginine against oxidative damage as a possible mechanism of its beneficial properties on spatial learning in ovariectomized rats," Basic and Clinical Neuroscience, Vol. 3, no. 5, pp. 36-44, 2012.
94. F. Khodabandehloo, M. Hosseini, Z. Rajaei, M. Soukhtanloo, E. Farrokhi, and M. Rezaeipour, "Brain tissue oxidative damage as a possible mechanism for the deleterious effect of a chronic high dose of estradiol on learning and memory in ovariectomized rats," Arquivos de Neuro-Psiquiatria, Vol. 71, no. 5, pp. 313-339, 2013.
95. G.-J. Biessels, A. Kamal, G. M. Ramakers et al., "Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats," Diabetes, Vol. 45, no. 9, pp. 1259-1266, 1996.
96. M. W. J. Strachan, B. M. Frier, and I. J. Deary, "Type 2 diabetes and cognitive impairment," Diabetic Medicine, Vol. 20, no. 1, pp. 1-2, 2003.
97. A. J. Sommerfield, I. J. Deary, and B. M. Frier, "Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes," Diabetes Care, Vol. 27, no. 10, pp. 2335-2340, 2004.
98. G.-J. Biessels, A. Kamal, I. J. A. Urban, B. M. Spruijt, D. W. Erkelens, and W. H. Gispen, "Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment," Brain Research, Vol. 800, no. 1, pp. 125-135, 1998.
99. E. Tamaddonfard, A. A. Farshid, S. Asri-Rezaee et al., "Crocin improved learning and memory impairments in streptozotocin-induced diabetic rats," Iranian Journal of Basic Medical Sciences, Vol. 16, no. 1, pp. 91-100, 2013.
100. G. Baydas, H. Canatan, and A. Turkoglu, "Comparative analysis of the protective effects of melatonin and vitamin E on streptozocin-induced diabetes mellitus," Journal of Pineal Research, Vol. 32, no. 4, pp. 225-230, 2002.
101. S. Celik, G. Bayda, and O. Ylmaz, "Influence of vitamin E on the levels of fatty acids and MDA in some tissues of diabetic rats," Cell Biochemistry & Function, Vol. 20, no. 1, pp. 67-71, 2002.
102. G. Baydas, E. Sonkaya, M. Tuzcu, A. Yasar, and E. Donder, "Novel role for gabapentin in neuroprotection of central nervous system in streptozotocine-induced diabetic rats," Acta Pharmacologica Sinica, Vol. 26, no. 4, pp. 417-422, 2005.
103. J. B. Majithiya and R. Balaraman, "Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats," Life Sciences, Vol. 78, no. 22, pp. 2615-2624, 2006.
104. C. M. Sena, P. Matafome, T. Louro, E. Nunes, R. Fernandes, and R. M. Seiça, "Metformin restores endothelial function in aorta of diabetic rats," British Journal of Pharmacology, Vol. 163, no. 2, pp. 424-437, 2011.
105. P. Faure, E. Rossini, N. Wiernsperger, M. J. Richard, A. Favier, and S. Halimi, "An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats," Diabetes, Vol. 48, no. 2, pp. 353-357, 1999.
106. D. Bonnefont-Rousselot, B. Raji, S. Walrand et al., "An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress," Metabolism, Vol. 52, no. 5, pp. 586-589, 2003.
107. D. Stepensky, M. Friedman, I. Raz, and A. Hoffman, "Pharmacokinetic-pharmacodynamic analysis of the glucose-lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect," Drug Metabolism and Disposition, Vol. 30, no. 8, pp. 861-868, 2002.
108. C. J. Bailey and R. C. Turner, "Metformin," The New England Journal of Medicine, Vol. 334, no. 9, pp. 574-579, 1996.
109. J. L. Sartoretto, G. A. N. Melo, M. H. C. Carvalho et al., "Metformin treatment restores the altered microvascular reactivity in neonatal streptozotocin-induced diabetic rats increasing NOS activity, but not NOS expression," Life Sciences, Vol. 77, no. 21, pp. 2676-2689, 2005.
110. G. M. Rubanyi, J. C. Romero, and P. M. Vanhoutte, "Flow-induced release of endothelium-derived relaxing factor," The American Journal of Physiology - Heart and Circulatory Physiology, Vol. 250, no. 6, pp. H822-H827, 1986.
111. K. Kamata and T. Kobayashi, "Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes," British Journal of Pharmacology, Vol. 119, no. 3, pp. 583-589, 1996.
112. R. Sadeghian, M. Fereidoni, M. Soukhtanloo, H. Azizi-Malekabadi, and M. Hosseini, "Decreased nitric oxide levels in the hippocampus may play a role in learning and memory deficits in ovariectomized rats treated by a high dose of estradiol," Arquivos de Neuro-Psiquiatria, Vol. 70, no. 11, pp. 874-879, 2012.
113. P. Gargiulo, D. Caccese, P. Pignatelli et al., "Metformin decreases platelet superoxide anion production in diabetic patients," Diabetes/Metabolism Research and Reviews, Vol. 18, no. 2, pp. 156-159, 2002.
114. C. Bellin, D. H. De Wiza, N. F. Wiernsperger, and P. Rösen, "Generation of reactive oxygen species by endothelial and smooth muscle cells: influence of hyperglycemia and metformin," Hormone and Metabolic Research, Vol. 38, no. 11, pp. 732-739, 2006.
115. C. J. Bailey, C. Wilcock, and J. H. B. Scarpello, "Metformin and the intestine," Diabetologia, Vol. 51, no. 8, pp. 1552-1553, 2008.
116. G. Kanigür-Sultuybek, Ş. B. Ozdas, A. Curgunlu, V. Tezcan, and I. Onaran, "Does metformin prevent short-term oxidant-induced DNA damage? In vitro study on lymphocytes from aged subjects," Journal of Basic and Clinical Physiology and Pharmacology, Vol. 18, no. 2, pp. 129-140, 2007.
117. P. Rösen and N. F. Wiernsperger, "Metformin delays the manifestation of diabetes and vascular dysfunction in Goto-Kakizaki rats by reduction of mitochondrial oxidative stress," Diabetes/Metabolism Research and Reviews, Vol. 22, no. 4, pp. 323-330, 2006.
118. N. Ouslimani, M. Mahrouf, J. Peynet et al., "Metformin reduces endothelial cell expression of both the receptor for advanced glycation end products and lectin-like oxidized receptor 1," Metabolism: Clinical and Experimental, Vol. 56, no. 3, pp. 308-313, 2007.
119. I. Orhan and M. Aslan, "Appraisal of scopolamine-induced antiamnesic effect in mice and in vitro antiacetylcholinesterase and antioxidant activities of some traditionally used Lamiaceae plants," Journal of Ethnopharmacology, Vol. 122, no. 2, pp. 327-332, 2009.
120. R. Alcázar, M. C. De la Torre, B. Rodríguez et al., "Neoclerodane diterpenoids from three species of Teucrium," Phytochemistry, Vol. 31, no. 11, pp. 3957-3960, 1992.
121. S. Bahramikia and R. Yazdanparast, "Phytochemistry and medicinal properties of Teucrium polium L. (Lamiaceae)," Phytotherapy Research, Vol. 26, no. 11, pp. 1581-1593, 2012.
122. A. Ansari Asl, M. Soveid, M. Azadbakht, G. R. Omrani, S. M. Solimani, and M. Samani, "The effect of extract of Teucrium polium on blood sugar and insulin levels of type 2 diabetic patients," Shiraz Medical Journal, Vol. 1, no. 1, pp. 1-5, 2000.
123. P. Ljubuncic, S. Dakwar, I. Portnaya, U. Cogan, H. Azaizeh, and A. Bomzon, "Aqueous extracts of Teucrium polium possess remarkable antioxidant activity in vitro," Evidence-Based Complementary and Alternative Medicine, Vol. 3, no. 3, pp. 329-338, 2006.
124. S. M. Suboh, Y. Y. Bilto, and T. A. Aburjai, "Protective effects of selected medicinal plants against protein degradation, lipid peroxidation and deformability loss of oxidatively stressed human erythrocytes," Phytotherapy Research, Vol. 18, no. 4, pp. 280-284, 2004.
125. T. K. Panovska, S. Kulevanova, and M. Stefova, "In vitro antioxidant activity of some Teucrium species (Lamiaceae)," Acta Pharmaceutica, Vol. 55, no. 2, pp. 207-214, 2005.
126. K. I. Qabaha, "Antimicrobial and free radical scavenging activities of five Palestinian medicinal plants," African Journal of Traditional, Complementary and Alternative Medicines, Vol. 10, no. 4, pp. 101-108, 2013.
127. C. Proestos, D. Sereli, and M. Komaitis, "Determination of phenolic compounds in aromatic plants by RP-HPLC and GCMS," Food Chemistry, Vol. 95, no. 1, pp. 44-52, 2006.
128. M. Rafieian-Kopaei and H. Nasri, "Comment on: preventive effect of Teucrium polium on learning and memory deficits in diabetic rats," Medical Science Monitor Basic Research, Vol. 19, pp. 208-209, 2013.
129. J. W. Baynes, "Role of oxidative stress in development of complications in diabetes," Diabetes, Vol. 40, no. 4, pp. 405-412, 1991.
130. A. Lapolla and D. Fedele, "Oxidative stress and diabetes: role in the development of chronic complications," Minerva Endocrinologica, Vol. 18, no. 3, pp. 99-108, 1993.
131. C. Luxford, R. T. Dean, and M. J. Davies, "Radicals derived from histone hydroperoxides damage nucleobases in RNA and DNA," Chemical Research in Toxicology, Vol. 13, no. 7, pp. 665-672, 2000.
132. K. Fukui, N.-O. Omoi, T. Hayasaka et al., "Cognitive impairment of rats caused by oxidative stress and aging, and its prevention by vitamin E," Annals of the New York Academy of Sciences, Vol. 959, pp. 275-284, 2002.